Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review
Environmental Pollution · 2023-12 · 339 · 122730
DOI: 10.1016/j.envpol.2023.122730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Environmental Pollution, 2023-12. Verfasst von Yubin Liu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China; Cell Ther…. Hauptthemen laut MEDLINE: Cigarette Smoking, Neoplasms. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 229 Literaturangaben. Gefördert von: Chuzhou Science and Technology Program, Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
Smoking is a serious global health issue. Cigarette smoking contains over 7000 different chemicals. The main harmful components include nicotine, acrolein, aromatic hydrocarbons and heavy metals, which play the key role for cigarette-induced inflammation and carcinogenesis. Growing evidences show that cigarette smoking and its components exert a remarkable impact on regulation of immunity and dysregulated immunity promotes inflammation and cancer. Therefore, this comprehensive and up-to-date review covers four interrelated topics, including cigarette smoking, inflammation, cancer and immune system. The known harmful chemicals from cigarette smoking were summarized. Importantly, we discussed in depth the impact of cigarette smoking on the formation of inflammatory or tumor microenvironment, primarily by affecting immune effector cells, such as macrophages, neutrophils, and T lymphocytes. Furthermore, the main molecular mechanisms by which cigarette smoking induces inflammation and cancer, including changes in epigenetics, DNA damage and others were further summarized. This article will contribute to a better understanding of the impact of cigarette smoking on inducing inflammation and cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China; Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China.
- Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, Sichuan, China.
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China; Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China; Sou…
- Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China.
Förderung
- Chuzhou Science and Technology Program
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Liu, Y., Lu, L., Yang, H., Wu, X., Luo, X., Shen, J., Xiao, Z., Zhao, Y., Du, F., Chen, Y., Deng, S., Cho, C. H., Li, Q., Li, X., Li, W., Wang, F., Sun, Y., Gu, L., Chen, M., & Li, M. (2023). Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review. Environmental Pollution, 339, 122730. https://doi.org/10.1016/j.envpol.2023.122730
Vancouver
Liu Y, Lu L, Yang H, Wu X, Luo X, Shen J, et al. Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review. Environmental Pollution. 2023;339:122730. doi:10.1016/j.envpol.2023.122730
BibTeX
@article{Liu2023,
author = {Liu, Yubin and Lu, Lan and Yang, Huan and Wu, Xu and Luo, Xinyue and Shen, Jing and Xiao, Zhangang and Zhao, Yueshui and Du, Fukuan and Chen, Yu and Deng, Shuai and Cho, Chi Hin and Li, Qianxiu and Li, Xiaobing and Li, Wanping and Wang, Fang and Sun, Yuhong and Gu, Li and Chen, Meijuan and Li, Mingxing},
title = {Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: A review},
journal = {Environmental Pollution},
year = {2023},
volume = {339},
pages = {122730},
doi = {10.1016/j.envpol.2023.122730}
}
EUVIMED